Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
TAAR5 Biologics Sequence Review Report 2026: Trace amine-associated receptor 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
TAAR5 Biologics Sequence Review Report 2026: Trace amine-associated receptor 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of TAAR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SSTR4 Biologics Sequence Review Report 2026: Somatostatin receptor type 4 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SSTR4 Biologics Sequence Review Report 2026: Somatostatin receptor type 4 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SSTR5 Biologics Sequence Review Report 2026: Somatostatin receptor type 5 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SSTR5 Biologics Sequence Review Report 2026: Somatostatin receptor type 5 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SSTR3 Biologics Sequence Review Report 2026: Somatostatin receptor type 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SSTR3 Biologics Sequence Review Report 2026: Somatostatin receptor type 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SSTR1 Biologics Sequence Review Report 2026: Somatostatin receptor type 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SSTR1 Biologics Sequence Review Report 2026: Somatostatin receptor type 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SSTR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
SCTR Biologics Sequence Review Report 2026: Secretin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
SCTR Biologics Sequence Review Report 2026: Secretin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of SCTR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RAMP2 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 2 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RAMP2 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RAMP3 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 3 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RAMP3 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RET Biologics Sequence Review Report 2026: Proto-oncogene tyrosine-protein kinase receptor Ret Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RET Biologics Sequence Review Report 2026: Proto-oncogene tyrosine-protein kinase receptor Ret Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RET protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTH2R Biologics Sequence Review Report 2026: Parathyroid hormone 2 receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTH2R Biologics Sequence Review Report 2026: Parathyroid hormone 2 receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTH2R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
RAMP1 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 1 Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
RAMP1 Biologics Sequence Review Report 2026: Receptor activity-modifying protein 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of RAMP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
PTGIR Biologics Sequence Review Report 2026: Prostacyclin receptor Similarity and Patent-Risk Signals
Latest Hotspot
8 min read
PTGIR Biologics Sequence Review Report 2026: Prostacyclin receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of PTGIR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →